LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.56 | 21.74 | 85 | 4838 | 0.0176 | 0.1911 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.56 | 21.74 | 738 | 4838 | 0.1525 | 0.5715 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.56 | 21.74 | 5 | 4838 | 0.0010 | -0.1718 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 49.56 | 21.74 | 846 | 4838 | 0.1748 | 0.5992 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.53 | 21.74 | 78 | 5150 | 0.0151 | 0.1758 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.53 | 21.74 | 733 | 5150 | 0.1423 | 0.5620 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.53 | 21.74 | 8 | 5150 | 0.0016 | -0.1190 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.53 | 21.74 | 859 | 5150 | 0.1668 | 0.5937 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.50 | 21.74 | 59 | 5425 | 0.0109 | 0.1336 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.50 | 21.74 | 739 | 5425 | 0.1362 | 0.5571 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.50 | 21.74 | 6 | 5425 | 0.0011 | -0.1493 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.50 | 21.74 | 846 | 5425 | 0.1559 | 0.5837 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 21.74 | 80 | 5768 | 0.0139 | 0.1756 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 21.74 | 717 | 5768 | 0.1243 | 0.5437 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 21.74 | 4 | 5768 | 0.0007 | -0.1896 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 21.74 | 822 | 5768 | 0.1425 | 0.5701 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.45 | 21.74 | 90 | 6023 | 0.0149 | 0.1914 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.45 | 21.74 | 728 | 6023 | 0.1209 | 0.5415 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.45 | 21.74 | 4 | 6023 | 0.0007 | -0.1883 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.45 | 21.74 | 812 | 6023 | 0.1348 | 0.5623 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.42 | 21.74 | 88 | 6125 | 0.0144 | 0.1875 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.42 | 21.74 | 723 | 6125 | 0.1180 | 0.5382 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.42 | 21.74 | 5 | 6125 | 0.0008 | -0.1652 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.42 | 21.74 | 793 | 6125 | 0.1295 | 0.5557 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.39 | 21.74 | 102 | 6112 | 0.0167 | 0.2093 | MN20160310_N01 | E13 |